Guardant Health, Inc. (NASDAQ:GH) Receives Consensus Recommendation of “Buy” from Brokerages

Guardant Health, Inc. (NASDAQ:GH – Get Free Report) has earned an average rating of “Buy” from the seventeen research firms that are currently covering the stock, Marketbeat Ratings reports. Sixteen investment analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average twelve-month target […]

Leave a Reply

Your email address will not be published.

Previous post Brookfield Business Partners L.P. (NYSE:BBU) Receives $32.50 Consensus Price Target from Analysts
Next post INPLAY OIL CP (OTCMKTS:IPOOF) Rating Lowered to Strong Sell at Zacks Research